The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
White matter imaging changes in subjective and mild cognitive impairment
Abstract
Background: To determine whether white matter (WM) memory network changes accompany early cognitive impairment and whether these changes represent early, pathologically independent axonal affection, we combined WM diffusion tensor imaging and cortical morphometric measurements of normal control subjects, patients with only subjective cognitive impairment (SCI), or mild cognitive impairment (MCI). Methods: We included 66 patients with SCI or MCI and 21 control subjects from a university‐hospital‐based memory clinic in a cross‐sectional study. Morphometric analysis was performed in FreeSurfer, and Tract‐Based Spatial Statistics was used for analysis of diffusion tensor imaging‐derived WM fractional anisotropy, radial diffusivity (DR), and mean diffusivity (MD). Relationships between WM measures and stage were assessed with whole‐brain voxelwise statistics and on a region‐of‐interest basis, with subsequent correction for cortical atrophy. Results: In SCI patients, as compared with control subjects, there were widespread changes in DR and MD. No significant differences in thickness could be demonstrated. In MCI patients, as compared with control subjects, there were widespread changes in DR, MD, and fractional anisotropy; the precuneal and inferior parietal cortices were thinner; and the hippocampus was smaller. Multiple logistic regression analysis eliminated morphometry as an explanatory variable in favor of DR/MD for all regions of interest, except in the precuneus, where both thickness and DR/MD were significant explanatory variables. Conclusions: WM tract degeneration is prominent in SCI and MCI patients, and is at least in part independent of overlying gray matter atrophy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Several studies have indicated similar FA reduction findings in patients with AD.
“as well as in patients with AD.35”
From A spatial imaging-transcriptomics paradigm for deciphering the molecular basis of microscopic MRI in the normal brain and Alzheimer’s disease (2025) · cites this paper as [67]
Citations
Cites
Desikan, R. S., Ségonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C., Blacker, D., Buckner, R. L., Dale, A. M., Maguire, R. P., Hyman, B. T., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.01.021 · Cited by 13,324
SMITH, S., & NICHOLS, T. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.061 · Cited by 5,250
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water
Song, S.-K., Sun, S.-W., Ramsbottom, M. J., Chang, C., Russell, J., & Cross, A. H. (2002) · NeuroImage · doi:10.1006/nimg.2002.1267 · Cited by 2,582
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · cited 1×
“Specific loss of layer II entorhinal cortex neurons seems to occur in very mild AD [12].”
BackgroundMorris, J. C. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004870 · Cited by 1,641
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases
Selkoe, D. J. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1054 · Cited by 863
Evolution of the neuropathology of Alzheimer's disease
Braak, H., & Braak, E. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb05866.x · Cited by 710
Outcome over seven years of healthy adults with and without subjective cognitive impairment
Reisberg, B., Shulman, M. B., Torossian, C., Leng, L., & Zhu, W. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2009.10.002 · Cited by 568
Reisberg, B., & Gauthier, S. (2007) · International Psychogeriatrics · doi:10.1017/s1041610207006412 · Cited by 338
White matter pathology isolates the hippocampal formation in Alzheimer's disease
Salat, D. H., Tuch, D. S., van der Kouwe, A. J. W., Greve, D. N., Pappu, V., Lee, S. Y., Hevelone, N. D., Zaleta, A. K., Growdon, J. H., Corkin, S., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.03.013 · Cited by 279
Diffusion tensor imaging in mild cognitive impairment and Alzheimerʼs disease: a review
Chua, T. C., Wen, W., Slavin, M. J., & Sachdev, P. S. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282f4594b · Cited by 273
Structural MRI biomarkers for preclinical and mild Alzheimer's disease
Fennema‐Notestine, C., Hagler, D. J., McEvoy, L. K., Fleisher, A. S., Wu, E. H., Karow, D. S., & Dale, A. M. (2009) · Human Brain Mapping · doi:10.1002/hbm.20744 · Cited by 233
Flagged first, then by citations
Research works printed but not linked: 35
- 10.1111/j.1365-2796.2004.01388.x · DOI · Paper page
- 10.1038/clpt.2009.166 · DOI
- 10.1002/ana.21706 · DOI · Paper page
- 10.1001/archneur.63.5.665 · DOI · Paper page
- Auer S, 1997, The GDS/FAST staging system, Int Psychogeriatr, 9, 167, 10.1017/S1041610297004869 · DOI
- Reisberg B, 1988, Global Deterioration Scale (GDS), Psychopharmacol Bull, 24, 661
- 10.1016/0306-4522(95)90397-P · DOI
- 10.1016/j.exger.2006.05.016 · DOI
- 10.1212/WNL.0b013e3181b16431 · DOI · Paper page
- 10.1016/j.neuroimage.2008.10.053 · DOI
- 10.1093/cercor/bhn232 · DOI
- 10.1016/j.neuroimage.2006.02.024 · DOI
- 10.1016/j.neubiorev.2006.06.003 · DOI
- 10.1016/j.neuroimage.2006.04.187 · DOI
- 10.1016/j.neurobiolaging.2005.03.007 · DOI
- 10.1002/ana.410200406 · DOI · Paper page
- 10.1155/2009/915041 · DOI · Paper page
- 10.1016/j.neuroimage.2008.06.005 · DOI
- 10.1016/0022-3956(75)90026-6 · DOI · Paper page
- 10.1177/089198879600900406 · DOI
- 10.1111/j.1532-5415.1992.tb03646.x · DOI
- 10.7326/0003-4819-107-4-481 · DOI
- 10.1136/jnnp.2004.050385 · DOI
- 10.3174/ajnr.A1059 · DOI
- 10.1016/S0896-6273(02)00569-X · DOI · Paper page
- 10.1093/cercor/bhg087 · DOI
- Smith SM, 2004, Advances in functional and structural MR image analysis and implementation as FSL, Neuroimage, 23, S208, 10.1016/j.neuroimage.2004.07.051 · DOI · Paper page
- 10.1016/j.neuroimage.2008.10.055 · DOI · Paper page
- 10.1016/S1361-8415(01)00036-6 · DOI
- 10.1109/42.796284 · DOI · Paper page
- 10.1016/j.neurobiolaging.2009.04.014 · DOI
- Torre JC, 2009, Cerebrovascular and cardiovascular pathology in Alzheimer's disease, Int Rev Neurobiol, 84, 35, 10.1016/S0074-7742(09)00403-6 · DOI
- Yukie M, 2009, Cingulate Neurobiology and Disease, 145, 10.1093/oso/9780198566960.003.0006 · DOI
- 10.1016/j.brainresbull.2009.08.004 · DOI · Paper page
- 10.1093/brain/awp257 · DOI · Paper page
Cited by
Sorted by citations
Glial activation and inflammation along the Alzheimer’s disease continuum
Nordengen, K., Kirsebom, B.-E., Henjum, K., Selnes, P., Gísladóttir, B., Wettergreen, M., Torsetnes, S. B., Grøntvedt, G. R., Waterloo, K. K., Aarsland, D., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1399-2 · Cited by 274
Self-citationNeuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease
Wang, X., Huang, W., Su, L., Xing, Y., Jessen, F., Sun, Y., Shu, N., & Han, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00395-3 · Cited by 265
Shu, N., Wang, X., Bi, Q., Zhao, T., & Han, Y. (2018) · Radiology · doi:10.1148/radiol.2017162696 · Cited by 135
Is Alzheimer’s a disease of the white matter?
Sachdev, P. S., Zhuang, L., Braidy, N., & Wen, W. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835ed6e8 · Cited by 137
Sun, Y., Dai, Z., Li, Y., Sheng, C., Li, H., Wang, X., Chen, X., He, Y., & Han, Y. (2016) · Radiology · doi:10.1148/radiol.2016151771 · Cited by 116
White matter alterations in early‐stage Alzheimer's disease: A tract‐specific study
Wen, Q., Mustafi, S. M., Li, J., Risacher, S. L., Tallman, E., Brown, S. A., West, J. D., Harezlak, J., Farlow, M. R., Unverzagt, F. W., et al. (2019) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.06.003 · Cited by 96
Cortical Thinning in Individuals with Subjective Memory Impairment
Meiberth, D., Scheef, L., Wolfsgruber, S., Boecker, H., Block, W., Träber, F., Erk, S., Heneka, M. T., Jacobi, H., Spottke, A., et al. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142322 · Cited by 84
Genome-wide analysis of attention deficit hyperactivity disorder in Norway
Zayats, T., Athanasiu, L., Sonderby, I., Djurovic, S., Westlye, L. T., Tamnes, C. K., Fladby, T., Aase, H., Zeiner, P., Reichborn-Kjennerud, T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122501 · Cited by 83
Ryu, S. Y., Lim, E. Y., Na, S., Shim, Y. S., Cho, J. H., Yoon, B., Hong, Y. J., & Yang, D. W. (2017) · International Psychogeriatrics · doi:10.1017/s1041610216002349 · Cited by 78
White matter degeneration in subjective cognitive decline: a diffusion tensor imaging study
Li, X.-Y., Tang, Z.-C., Sun, Y., Tian, J., Liu, Z.-Y., & Han, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.10091 · Cited by 65
The DELCODE Study Group, Brueggen, K., Dyrba, M., Cardenas-Blanco, A., Schneider, A., Fliessbach, K., Buerger, K., Janowitz, D., Peters, O., Menne, F., et al. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09429-3 · Cited by 51
Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease
Reas, E. T., Hagler, D. J., White, N. S., Kuperman, J. M., Bartsch, H., Cross, K., Loi, R. Q., Balachandra, A. R., Meloy, M. J., Wierenga, C. E., et al. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0281-7 · Cited by 35
Shen, Y., Shen, Y., Wang, M., Jin, K., Yang, P., Cao, Z., Zhu, Q., Zhao, Z., Li, H., Han, L., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116073 · Cited by 16
Metadata
- Authors
- Selnes, P., Fjell, A. M., Gjerstad, L., Bjørnerud, A., Wallin, A., Due-Tønnessen, P., Grambaite, R., Stenset, V., & Fladby, T.
- Affiliations
- Department of Neurology Faculty Division Akershus University Hospital University of Oslo Lørenskog Norway
- Department of Psychology Center for the Study of Human Cognition University of Oslo Oslo Norway
- Department of Neurology Oslo University Hospital Rikshospitalet Oslo Norway
- Department of Radiology Oslo University Hospital Rikshospitalet Oslo Norway
- Department of Neurochemistry and Psychiatry Institute of Neuroscience and Physiology Sahlgrenska Academy at Göteborg University SU/Sahlgrenska Gothenburg Sweden
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2012-10
- Volume
- 8
- Issue
- 5S
- ISSN
- 1552-5260
- 1552-5279
- Cited by
- 75
- References
- 13
- Language
- en
- Funders
- Norges Forskningsråd
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review